Author:
Lee Yun-Han,Moon Ik-Jae,Hur Bin,Park Jeong-Hoh,Han Kil-Hwan,Uhm Seok-Yong,Kim Yong-Joo,Kang Koo-Jeong,Park Jong-Wook,Seu Young-Bae,Kim Young-Ho,Park Jong-Gu
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference47 articles.
1. Dolnick, B.J. Antisense agents in cancer research and therapeutics. Cancer Invest. 9, 185–194 (1991).
2. Bennett, C.F. & Cowsert, L.M. Antisense oligonucleotides as a tool for gene functionalization and target validation. Biochim. Biophys. Acta 1489, 19–30 (1999).
3. Thompson, C.B., Challoner, P.B., Neiman, P.E. & Groudine, M. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 314, 363–366 (1985).
4. Melani, C., Rivoltini, L., Parmiani, G., Calabretta, B. & Colombo, M.P. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res. 51, 2897–2901 (1991).
5. Anfossi, G., Gewirtz, A.M. & Calabretta, B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc. Natl. Acad. Sci. USA 86, 3379–3383 (1989).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献